1-20 of 31
Wiesław Wiktor Jêdrzejczak
Close
Sort by
Journal Articles

Patient-Reported Quality of Life before and after Stopping Treatment in the ENESTfreedom Trial of Treatment-Free Remission for Patients with Chronic Myeloid Leukemia in Chronic Phase

Andreas Hochhaus, MD, Maria Teresa Gómez Casares, MDPhD, Jesper Stentoft, MD PhD, Eibhlin Conneally, MB, MRCP, MRCPath, PhD, Valentin García-Gutiérrez, MD, Norbert Gattermann, MD, Wieslaw Wiktor-Jedrzejczak, MD, Philipp D. Le Coutre, MD, Bruno Martino, MD, Susanne Saussele, MD, Francis J. Giles, MB, MD FRCPI, FRCPath, Jerald P. Radich, David M. Ross, MBBS, PhD FRACP, FRCPA, Hans D. Menssen, MD PhD, Weiping Deng, Patricia Brandt, Ari Gnanasakthy, MBA, MSc, Veronique Bedoucha, Giuseppe Saglio, MD
Journal: Blood
Blood (2016) 128 (22): 3066.
https://doi.org/10.1182/blood.V128.22.3066.3066
Published: 2016
Journal Articles

Romiplostim in Thrombocytopenic Patients with Low- or Int-1- Risk MDS Results in Reduced Bleeding without Impacting Leukemic Progression: Final Follow-up Results from a Randomized, Double-Blind, Placebo-Controlled Study

Hagop Kantarjian, Pierre Fenaux, Mikkael A. Sekeres, MD, Jeffrey Szer, Uwe Platzbecker, MD, Andrea Kuendgen, Gianluca Gaidano, Wieslaw Wiktor-Jedrzejczak, MD, Nancy Carpenter, Bhakti Mehta, Janet Franklin, Aristoteles Giagounidis
Journal: Blood
Blood (2016) 128 (22): 2000.
https://doi.org/10.1182/blood.V128.22.2000.2000
Published: 2016
Journal Articles

Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3 -ITD + normal karyotype AML patients

Clinical Trials & Observations
Marta Libura, Sebastian Giebel, Beata Piatkowska-Jakubas, Marta Pawelczyk, Izabella Florek, Karolina Matiakowska, Bozena Jazwiec, Katarzyna Borg, Iwona Solarska, Magdalena Zawada, Sylwia Czekalska, Jolanta Libura, Malgorzata Jakobczyk, Karolina Karabin, Monika Paluszewska, Malgorzata Calbecka, Justyna Gajkowska-Kulik, Grazyna Gadomska, Marek Kielbinski, Anna Ejduk, Dariusz Kata, Sebastian Grosicki, Agnieszka Wierzbowska, Slawomira Kyrcz-Krzemien, Krzysztof Warzocha, Kazimierz Kuliczkowski, Aleksander Skotnicki, Jerzy Holowiecki, Wieslaw Wiktor Jedrzejczak, Olga Haus
Journal: Blood
Blood (2016) 127 (3): 360–362.
https://doi.org/10.1182/blood-2015-08-662130
Published: 2016
Includes: Supplemental data
Journal Articles

Hemophagocytic Lymphohistiocytosis (HLH) in 44 Adults: Results from the Retrospective Polish Registry

Rafal Machowicz, MD MSc, Piotr Boguradzki, MD PhD, Joanna Drozd-Sokolowska, MD PhD, Edyta Cichocka, MD PhD, Renata Guzicka-Kazimierczak, MD PhD, Agnieszka Piekarska, MD PhD, Justyna Gil, MD PhD, Krzysztof Madry, MD PhD, Bartosz Garus, MD PhD, Dorota Zdunczyk, MD PhD, Slawomir Rejowski, MD PhD, Patrycja Zielinska, MD PhD, Lukasz Bolkun, Patrycja Mensah-Glanowska, MD PhD, Malgorzata Paszkowska-Kowalewska, PhD, Anna Waszczuk-Gajda, MD PhD, Michal Gorka, MD, Katarzyna Romanowska-Prochnicka, MD PhD, Alina Swiderska, MD PhD, Mateusz Ziarkiewicz, MD PhD, Emilian Snarski, PhD MD, Katarzyna Brzezniakiewicz-Janus, MD PhD, Agnieszka Szymczyk, MD PhD, Wanda Knopinska-Posluszny, MD PhD, Jadwiga Dwilewicz-Trojaczek, MD PhD, Wieslaw Wiktor-Jedrzejczak, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4613.
https://doi.org/10.1182/blood.V126.23.4613.4613
Published: 2015
Journal Articles

Romiplostim in Thrombocytopenic Patients (Pts) with Low-Risk or Intermediate-1 (Int-1)-Risk Myelodysplastic Syndrome (MDS) Results in Reduced Bleeding without Impacting Leukemic Progression: Updated Follow-up Results from a Randomized, Double-Blind, Placebo (PBO)-Controlled Study

Hagop Kantarjian, MD, Ghulam J. Mufti, MD PhD, Pierre Fenaux, MD PhD, Mikkael A. Sekeres, MD MS, Jeffrey Szer, MB BS FRACP, Uwe Platzbecker, MD, Andrea Kuendgen, MD, Gianluca Gaidano, Wieslaw Wiktor-Jedrzejczak, MD PhD, Janet Franklin, MD MPH, Aristoteles Giagounidis, MD
Journal: Blood
Blood (2015) 126 (23): 2863.
https://doi.org/10.1182/blood.V126.23.2863.2863
Published: 2015
Journal Articles

Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results

Clinical Trials & Observations
Michael L. Wang, Kristie A. Blum, Peter Martin, Andre Goy, Rebecca Auer, Brad S. Kahl, Wojciech Jurczak, Ranjana H. Advani, Jorge E. Romaguera, Michael E. Williams, Jacqueline C. Barrientos, Ewa Chmielowska, John Radford, Stephan Stilgenbauer, Martin Dreyling, Wieslaw Wiktor Jedrzejczak, Peter Johnson, Stephen E. Spurgeon, Liang Zhang, Linda Baher, Mei Cheng, Dana Lee, Darrin M. Beaupre, Simon Rule
Journal: Blood
Blood (2015) 126 (6): 739–745.
https://doi.org/10.1182/blood-2015-03-635326
Published: 2015
Includes: Supplemental data
Journal Articles

Efficacy and Safety Based on Duration of Treatment of Panobinostat Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma in the Phase 3 Panorama 1 Study

Jesus San Miguel, MD PhD, Vania TM Hungria, Sung-Soo Yoon, MD PhD, Meral Beksac, MD, Meletios A. Dimopoulos, Ashraf Elghandour, MD, Wieslaw Wiktor Jedrzejczak, MD, Andreas Guenther, MD, Thanyaphong Na Nakorn, MD PhD, Noppadol Siritanaratkul, MD, Robert L Schlossman, MD, Jian Hou, MD PhD, Philippe Moreau, MD, Sagar Lonial, MD, Jae-Hoon Lee, Hermann Einsele, MD, Hans Salwender, MD, Monika Sopala, Suman Redhu, Sofia Paul, PhD, Claudia Corrado, Florence Binlich, Paul G. Richardson
Journal: Blood
Blood (2014) 124 (21): 4742.
https://doi.org/10.1182/blood.V124.21.4742.4742
Published: 2014
Journal Articles

Single-Agent Ibrutinib Demonstrates Safety and Durability of Response at 2 Years Follow-up in Patients with Relapsed or Refractory Mantle Cell Lymphoma: Updated Results of an International, Multicenter, Open-Label Phase 2 Study

Michael Wang, MD, Simon Rule, MD, Peter Martin, MD, Andre Goy, MD, Rebecca Auer, MD PhD, Brad S. Kahl, MD, Wojciech Jurczak, Ranjana Advani, MD, Jorge E. Romaguera, MD, Michael E. Williams, MD, Jacqueline C. Barrientos, MD, Ewa Chmielowska, MD, John Radford, Stephan Stilgenbauer, MD, Martin Dreyling, Wieslaw Wiktor Jedrzejczak, MD, Peter W Johnson, MD, Stephen E. Spurgeon, MD, Liang Zhang, MD PhD, Linda Baher, Mei Cheng, PhD, Darrin M. Beaupre, MD, Kristie A. Blum, MD
Journal: Blood
Blood (2014) 124 (21): 4453.
https://doi.org/10.1182/blood.V124.21.4453.4453
Published: 2014
Journal Articles

Conditioning Intensity Does Not Influence the Outcome of Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome. a Joint Study By the Polish Adult Leukemia Group and the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation

Lidia Gil, MD PhD, Jadwiga Dwilewicz-Trojaczek, MDPhD, Jan Styczynski, MD PhD, Marek Ussowicz, MDPhD, Krzysztof Kalwak, MD PhD, Ewa Gorczynska, MDPhD, Miroslaw Markiewicz, MD PhD, Monika Dzierzak-Mietla, MD, Patrycja Zielinska, MD PhD, Martyna Borowczyk, Adam Nowicki, MD, Marta Baranska, MD, Mieczyslaw Komarnicki, Maria Bieniaszewska, MD, Andrzej Hellmann, MD PhD, Grzegorz Basak, MD PhD, Wieslaw Wiktor Jedrzejczak, MD, Andrzej Lange, MDPhD, Kazimierz Halaburda, MD, Katarzyna Drabko, MDPhD, Agnieszka Zaucha-Prazmo, Beata Jakubas, MDPhD, Patrycja Mensah-Glanowska, Piotr Rzepecki, PhD MD, Anna Pieczonka, MD, Jacek Wachowiak, MD PhD, Agnieszka Wierzbowska, MD PhD, Jaroslaw Dybko, MD PhD, Tomasz Wrobel, MDPhD, Sebastian Giebel
Journal: Blood
Blood (2014) 124 (21): 2564.
https://doi.org/10.1182/blood.V124.21.2564.2564
Published: 2014
Journal Articles

Treatment with Romiplostim, a Thrombopoietin-Receptor Agonist, in Thrombocytopenic Patients (Pts) with Low or Intermediate-1 (Int-1) Risk Myelodysplastic Syndrome (MDS): Updated Follow-up Results for Acute Myeloid Leukemia (AML) and Survival from a Randomized, Double-Blind, Placebo (PBO)-Controlled Study

Hagop M. Kantarjian, Ghulam Mufti, Pierre Fenaux, Mikkael Sekeres, Jeffrey Szer, Uwe Platzbecker, Andrea Kuendgen, MD, Gianluca Gaidano, Wieslaw Wiktor-Jedrzejczak, Amelia Orejudos, Angela Lopez, Aristoteles Giagounidis
Journal: Blood
Blood (2014) 124 (21): 3276.
https://doi.org/10.1182/blood.V124.21.3276.3276
Published: 2014
Journal Articles

Characterization of the Incidence and Management of Gastrointestinal Toxicity in the Phase 3 Panorama 1 Study of Panobinostat Plus Bortezomib and Dexamethasone Versus Placebo Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma

Paul G. Richardson, Vania T M Hungria, MDPhD, Sung-Soo Yoon, MD PhD, Meral Beksac, MD, Meletios A. Dimopoulos, MD, Ashraf Elghandour, MD, Wieslaw Wiktor Jedrzejczak, MD, Andreas Guenther, MD, Thanyaphong Na Nakorn, MD PhD, Noppadol Siritanaratkul, MD, Robert L. Schlossman, MD, Jian Hou, MD PhD, Philippe Moreau, Sagar Lonial, MD, Jae Hoon Lee, MD PhD, Hermann Einsele, Hans Salwender, MD, Monika Sopala, Ashok Panneerselvam, Suman Redhu, Claudia Corrado, Florence Binlich, Jesus F. San Miguel
Journal: Blood
Blood (2014) 124 (21): 2120.
https://doi.org/10.1182/blood.V124.21.2120.2120
Published: 2014
Journal Articles

EBMT Prospective Non-Interventional Study On Allogeneic Hematopoietic Stem Cell Transplantation In T-Prolymphocytic Leukemia (T-PLL). Preliminary Analysis Of 43 Patients

Wieslaw Wiktor Jedrzejczak, M.D., Ph.D., Simona Iacobelli, Ph. D., Jennifer D.C. Hoek, Ph.D., Joanna E Drozd-Sokolowska, M.D., Ph.D., Michael Potter, MD, PhD, Gerald Wulf, MD, Patrice Chevallier, MD, PhD, Per T. Ljungman, MD, PhD, Yener Koc, MD, Johannes Schetelig, MD, M. Sc, Theo de Witte, MD, Nicolaus Kroeger, MD, Peter Dreger, MD
Journal: Blood
Blood (2013) 122 (21): 3336.
https://doi.org/10.1182/blood.V122.21.3336.3336
Published: 2013
Journal Articles

Treatment With Romiplostim, a Thrombopoietin-Receptor Agonist, In Thrombocytopenic Patients With Low Or Intermediate-1 Risk Myelodysplastic Syndrome: Updated Follow-Up Results For Acute Myeloid Leukemia and Survival From a Randomized, Double-Blind, Placebo-Controlled Study

Hagop M. Kantarjian, MD, Ghulam J. Mufti, MD, PhD, Pierre Fenaux, MD, PhD, Mikkael A. Sekeres, MD, MS, Jeffrey Szer, MBBS, Uwe Platzbecker, MD, PhD, Andrea Kuendgen, MD, Gianluca Gaidano, Wieslaw Wiktor-Jedrzejczak, Anne Meibohm, PhD, Angela Lopez, Aristoteles Giagounidis, MD
Journal: Blood
Blood (2013) 122 (21): 1553.
https://doi.org/10.1182/blood.V122.21.1553.1553
Published: 2013
Journal Articles

FLT3-ITD and MLL -PTD Mutations Influence the Expression of MDR1, MRP1 and BCRP mRNA in Adult Acute Myeloid Leukemia

Barbara Nasilowska-Adamska, Iwona Solarska, Monika Paluszewska, Wieslaw Wiktor Jedrzejczak, Piotr Rzepecki, Bozena Marianska, Krzysztof Warzocha
Journal: Blood
Blood (2012) 120 (21): 1334.
https://doi.org/10.1182/blood.V120.21.1334.1334
Published: 2012
Journal Articles

Bendamustine in Monotherapy and in Combination Regimens in the Treatment of Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma – a Retrospective Analysis

Iwona Hus, Dariusz Jawniak, Magdalena Gorska-Kosicka, Aleksandra Butrym, Justyna Dzietczenia, Tomasz Wrobel, Grzegorz Mazur, MD, PhD, Ewa Lech-Maranda, Krzysztof Warzocha, MD, PhD, Anna Waszczuk-Gajda, Wieslaw Wiktor-Jedrzejczak, MD, PhD, Malgorzata Krawczyk-Kulis, Slawomira Kyrcz-Krzemien, MD PhD Prof, Lidia Poplawska, Jan Walewski, Anna Dmoszynska
Journal: Blood
Blood (2012) 120 (21): 4602.
https://doi.org/10.1182/blood.V120.21.4602.4602
Published: 2012
Journal Articles

Daunorubicine, Cytarabine and Cladribine (DAC) Vs Daunorubicine and Cytarabine (DA) Induction Treatment in Elderly Acute Myeloid Leukemia (AML) Patients – Results of the Prospective, Multicenter, Randomized Trial of the Polish Adult Leukemia Group (PALG)

Agnieszka Pluta, MD, PhD, Tadeusz Robak, MD, PhD, Agata Wrzesien-Kus, MD, PhD, Bozena Katarzyna Budziszewska, MD, PhD, Kazimierz Sulek, MD, PhD, Ewa Wawrzyniak, PhD, Magdalena Czemerska, MD, Malgorzata Zwolinska, MD, Aleksandra Golos, MD, Aleksandra Holowiecka-Goral, MD, PhD, Slawomira Kyrcz-Krzemien, MD, PhD, Jaroslaw Piszcz, MD, PhD, Janusz Kloczko, MD, PhD, Monika Mordak, MD, Andrzej Lange, MD, PhD, Małgorzata Razny, MD, PhD, Krzysztof Madry, MD, PhD, Wieslaw Wiktor-Jedrzejczak, MD, PhD, Sebastian Grosicki, MD, PhD, Aleksandra Butrym, MD, Kazimierz Kuliczkowski, MD PhD, Krzysztof Warzocha, MD, PhD, Jerzy Holowiecki, MD, PhD, Agnieszka Wierzbowska, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3602.
https://doi.org/10.1182/blood.V120.21.3602.3602
Published: 2012
Journal Articles

Treatment with the Thrombopoietin (TPO)-Receptor Agonist Romiplostim in Thrombocytopenic Patients (Pts) with Low or Intermediate-1 (int-1) Risk Myelodysplastic Syndrome (MDS): Follow-up AML and Survival Results of a Randomized, Double-Blind, Placebo (PBO)-Controlled Study

Hagop M. Kantarjian, MD, Ghulam J. Mufti, MD, Pierre Fenaux, MD, PhD, Mikkael A. Sekeres, MD, MS, Jeffrey Szer, MBBS, Uwe Platzbecker, MD, Andrea Kuendgen, Gianluca Gaidano, MD, PhD, Wieslaw Wiktor-Jedrzejczak, MD, PhD, John M. Bennett, MD, Anne Meibohm, PhD, Allen S. Yang, MD, PhD, Aristoteles Giagounidis, MD
Journal: Blood
Blood (2012) 120 (21): 421.
https://doi.org/10.1182/blood.V120.21.421.421
Published: 2012
Journal Articles

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia

Clinical Trials & Observations
Tadeusz Robak, Jerzy Windyga, Jacek Trelinski, Mario von Depka Prondzinski, Aristoteles Giagounidis, Chantal Doyen, Ann Janssens, María Teresa Álvarez-Román, Isidro Jarque, Javier Loscertales, Gloria Pérez Rus, Andrzej Hellmann, Wiesław Wiktor Jêdrzejczak, Kazimierz Kuliczkowski, Lana M. Golubovic, Dusica Celeketic, Andrei Cucuianu, Emanuil Gheorghita, Mihaela Lazaroiu, Ofer Shpilberg, Dina Attias, Elena Karyagina, Kalinina Svetlana, Kateryna Vilchevska, Nichola Cooper, Kate Talks, Mukhyaprana Prabhu, Prasad Sripada, T. P. R. Bharadwaj, Henrik Næsted, Niels J. Ø. Skartved, Torben P. Frandsen, Mimi F. Flensburg, Peter S. Andersen, Jørgen Petersen
Journal: Blood
Blood (2012) 120 (18): 3670–3676.
https://doi.org/10.1182/blood-2012-06-438804
Published: 2012
Journal Articles

Rac2-MRC-cIII–generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors

Margaret Nieborowska-Skorska, Piotr K. Kopinski, Regina Ray, Grazyna Hoser, Danielle Ngaba, Sylwia Flis, Kimberly Cramer, Mamatha M. Reddy, Mateusz Koptyra, Tyrone Penserga, Eliza Glodkowska-Mrowka, Elisabeth Bolton, Tessa L. Holyoake, Connie J. Eaves, Sabine Cerny-Reiterer, Peter Valent, Andreas Hochhaus, Timothy P. Hughes, Heiko van der Kuip, Martin Sattler, Wieslaw Wiktor-Jedrzejczak, Christine Richardson, Adrienne Dorrance, Tomasz Stoklosa, David A. Williams, Tomasz Skorski
Journal: Blood
Blood (2012) 119 (18): 4253–4263.
https://doi.org/10.1182/blood-2011-10-385658
Published: 2012
Includes: Supplemental data
Journal Articles

A Phase 3 Study Evaluating the Efficacy and Safety of Lenalidomide (Len) Combined with Melphalan and Prednisone Followed by Continuous Lenalidomide Maintenance (MPR-R) in Patients (Pts) ≥ 65 Years (Yrs) with Newly Diagnosed Multiple Myeloma (NDMM): Updated Results for Pts Aged 65–75 Yrs Enrolled in MM-015

Antonio Palumbo, MD, Zdenek Adam, Martin Kropff, MD, Robin Foà, John Catalano, MBBS FRACP FRCPA, Heinz Gisslinger, MD, Wieslaw Wiktor-Jedrzejczak, MD, PhD, Michel Delforge, MD, PhD, Katja Weisel, MD, Nicola Cascavilla, MD, Jan Van Droogenbroeck, Genadi Iosava, MD, Michele Cavo, MD, Joan Blade, Meral Beksac, MD, Ivan Spicka, MD, PhD, Torben Plesner, MD, Zhinuan Yu, Lindsey Herbein, Jay Mei, MD, PhD, Christian J. Jacques, Meletios Athanasios Dimopoulos, MD
Journal: Blood
Blood (2011) 118 (21): 475.
https://doi.org/10.1182/blood.V118.21.475.475
Published: 2011